Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer

por Tekedereli, Ibrahim, Alpay, S. Neslihan, Tavares, Clint D. J., Cobanoglu, Zehra E., Kaoud, Tamer S., Sahin, Ibrahim, Sood, Anil K., Lopez-Berestein, Gabriel, Dalby, Kevin N., Ozpolat, Bulent
Publicado 2012